Keyphrases
Morphine
100%
Molecular Therapeutics
50%
Molecular Mechanism
50%
Obstetric Anesthesiology
50%
Therapeutic Target
50%
Pregabalin
50%
Pain Medicine
50%
Chondrosarcoma
50%
Chemotherapy-induced Peripheral Neuropathy
50%
Obstetric Pain
50%
Human Spinal Cord
50%
Antenatal Therapy
50%
Radioresistance
50%
Chemotherapy
50%
Positive Airway Pressure
50%
Scratching Behavior
50%
Fetal Growth Restriction
50%
Randomized Placebo-controlled Trial
50%
Thromboembolic Complications
50%
Opioid Receptors
50%
Noncardiac Surgery
50%
Pragmatic Clinical Trial
50%
Obstructive Sleep Apnea
50%
Distal Symmetric Polyneuropathy
50%
Gastrin-releasing Peptide Receptor (GRPr)
50%
Rotational Thromboelastometry (ROTEM)
50%
Response Predictors
50%
Sleep Apnea
50%
Opioid-induced
50%
Electronic Medical Records
50%
Perioperative Antibiotics
50%
Randomized Crossover Design
50%
Healthy Volunteers
50%
Epidural
50%
Pharmacokinetic Effects
50%
Clinical Effect
50%
Methadone
50%
Analgesia
47%
Cefazolin
40%
Chemotherapy Resistance
25%
Radiation Resistance
25%
Tumor
25%
Heat Pain
25%
Dermatome
25%
Placebo
22%
Receptor Isoforms
21%
Intraepidermal Nerve Fiber Density
21%
Antibiotics
20%
Antibiotic Doses
20%
Second Dose
20%
Medicine and Dentistry
Morphine
100%
Analgesia
59%
Obstetrics
50%
Positive Airway Pressure
50%
Pain Medicine
50%
Anesthesiology
50%
Chondrosarcoma
50%
Thromboembolism
50%
Radiosensitivity
50%
Fetus Growth
50%
Noncardiac Surgery
50%
Randomized Clinical Trial
50%
Obstructive Sleep Apnea
50%
Thromboelastometry
50%
Systematic Review
50%
Electronic Patient Record
50%
Polyneuropathy
50%
Gastrin Releasing Peptide Receptor
50%
Volunteer
50%
Pharmacokinetics
50%
Methadone
50%
Opioid Receptor
50%
Cefazolin
40%
Nerve Fiber
35%
Antibiotics
30%
Neoplasm
25%
Carboxy Terminal Sequence
21%
Neuropathy
21%
Pruritus
21%
Dermatome
20%
Clinician
20%
Platelet
17%
Birth Weight
16%
Physical Disease by Body Function
14%
Isotopes of Calcium
14%
Primary Tumor
12%
Oxygen Desaturation
11%
Apnea
11%
Hypopnea
11%
Gestational Age
11%
Pain Threshold
10%
Cardiopulmonary Bypass
10%
Surgical Infection
10%
Repeated Drug Dose
10%
Adverse Effect
10%
Fibrin Clot
7%
Tail
7%
Calcium Imaging
7%
Reverse Transcription Polymerase Chain Reaction
7%
Partial Thromboplastin Time
7%
